MapLight Therapeutics, Inc. (MPLT) vs Strata Critical Medical, Inc. (SRTA)
A side-by-side comparison of MapLight Therapeutics, Inc. and Strata Critical Medical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MPLT
MapLight Therapeutics, Inc.
$9.69HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SRTA
Strata Critical Medical, Inc.
$4.75HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — MPLT vs SRTA
growth of $100 · dividends reinvested · last 1yMPLT -49.4% (-49.4%/yr)SRTA -4.4% (-4.4%/yr)SRTA compounded faster over this window
MPLT SRTA
MPLT vs SRTA: by the numbers
- •MPLT is the larger company ($411M vs $411M market cap).
- •SRTA is profitable (15.71% net margin) while MPLT runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | MPLT | SRTA |
|---|---|---|
| P/E ratio | N/A | 9.54 |
| P/S ratio | N/A | 1.61 |
| P/B ratio | 1.18 | 1.47 |
Profitability
| Metric | MPLT | SRTA |
|---|---|---|
| Gross margin | 0.00% | 20.56% |
| Operating margin | 0.00% | -7.97% |
| Net margin | 0.00% | 15.71% |
| ROE | -65.99% | 14.40% |
| ROIC | -69.35% | -7.11% |
Growth (annualized)
| Metric | MPLT | SRTA |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 46.05% |
| Total return CAGR (5Y) | N/A | -13.77% |
Frequently asked
- Is MPLT or SRTA more profitable?
- SRTA runs the higher net margin — MPLT at 0.00% versus SRTA at 15.71%.
Go deeper
Dig into the metrics
Strata Critical Medical P/E ratioMapLight Therapeutics ROEStrata Critical Medical ROEMapLight Therapeutics operating marginStrata Critical Medical operating marginMapLight Therapeutics revenue growthStrata Critical Medical revenue growthMapLight Therapeutics free cash flowStrata Critical Medical free cash flow
MapLight Therapeutics & Strata Critical Medical appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.